Evidence map›Paper›PMID 39703602›Full record

ReviewClinical ophthalmology (Auckland, N.Z.)2024

Artificial Intelligence in Uveitis: Innovations in Diagnosis and Therapeutic Strategies.

Siva Raman Bala Murugan, Srinivasan Sanjay, Anjana Somanath, Padmamalini Mahendradas, Aditya Patil, Kirandeep Kaur, Bharat Gurnani

Abstract readReview
In one paragraph

Review in Clinical ophthalmology (Auckland, N.Z.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Siva Raman Bala MuruganDepartment of Uveitis and Ocular Inflammation Uveitis Clinic, Aravind Eye Hospital, Pondicherry, 605007, India.
Srinivasan SanjayDepartment of Clinical Services, Singapore National Eye Centre, Third Hospital Ave, Singapore City, 168751, Singapore.ORCID 0000-0001-9756-1207
Anjana SomanathDepartment of Uveitis and Ocular Inflammation, Aravind Eye Hospital, Madurai, Tamil Nadu.
Padmamalini MahendradasDepartment of Uveitis and Ocular Immunology, Narayana Nethralaya, Bangalore, Karnataka, 560010, India.
Aditya PatilDepartment of Uveitis and Ocular Immunology, Narayana Nethralaya, Bangalore, Karnataka, 560010, India.
Kirandeep KaurDepartment of Cataract, Pediatric Ophthalmology and Strabismus, Gomabai Netralaya and Research Centre, Neemuch, Madhya Pradesh, 458441, India.
Bharat GurnaniDepartment of Cataract, Cornea and Refractive Surgery, Gomabai Netralaya and Research Centre, Neemuch, Madhya Pradesh, 458441, India.ORCID 0000-0003-0848-5172

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the dynamic field of ophthalmology, artificial intelligence (AI) is emerging as a transformative tool in managing complex conditions like uveitis. Characterized by diverse inflammatory responses, uveitis presents significant diagnostic and therapeutic challenges. This systematic review explores the role of AI in advancing diagnostic precision, optimizing therapeutic approaches, and improving patient outcomes in uveitis care. A comprehensive search of PubMed, Scopus, Google Scholar, Web of Science, and Embase identified over 10,000 articles using primary and secondary keywords related to AI and uveitis. Rigorous screening based on predefined criteria reduced the pool to 52 high-quality studies, categorized into six themes: diagnostic support algorithms, screening algorithms, standardization of Uveitis Nomenclature (SUN), AI applications in management, systemic implications of AI, and limitations with future directions. AI technologies, including machine learning (ML) and deep learning (DL), demonstrated proficiency in anterior chamber inflammation detection, vitreous haze grading, and screening for conditions like ocular toxoplasmosis. Despite these advancements, challenges such as dataset quality, algorithmic transparency, and ethical concerns persist. Future research should focus on developing robust, multimodal AI systems and fostering collaboration among academia and industry to ensure equitable, ethical, and effective AI applications. The integration of AI heralds a new era in uveitis management, emphasizing precision medicine and enhanced care delivery.

Indexed as

AIartificial intelligencedeep learningDLmachine learningMLOCToptical coherence tomographyuveitis management

Identifiers

PMID39703602
PMCPMC11656483

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.